Cargando…
Model‐Based Network Meta‐Analysis: A Framework for Evidence Synthesis of Clinical Trial Data
Model‐based meta‐analysis (MBMA) is increasingly used in drug development to inform decision‐making and future trial designs, through the use of complex dose and/or time course models. Network meta‐analysis (NMA) is increasingly being used by reimbursement agencies to estimate a set of coherent rela...
Autores principales: | Mawdsley, D, Bennetts, M, Dias, S, Boucher, M, Welton, NJ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999602/ https://www.ncbi.nlm.nih.gov/pubmed/27479782 http://dx.doi.org/10.1002/psp4.12091 |
Ejemplares similares
-
Joining the Dots: Linking Disconnected Networks of Evidence Using Dose-Response Model-Based Network Meta-Analysis
por: Pedder, Hugo, et al.
Publicado: (2021) -
Modelling time‐course relationships with multiple treatments: Model‐based network meta‐analysis for continuous summary outcomes
por: Pedder, Hugo, et al.
Publicado: (2019) -
Evidence Synthesis for Decision Making 2: A Generalized Linear Modeling Framework for Pairwise and Network Meta-analysis of Randomized Controlled Trials
por: Dias, Sofia, et al.
Publicado: (2013) -
The Many Flavors of Model‐Based Meta‐Analysis: Part I—Introduction and Landmark Data
por: Boucher, M, et al.
Publicado: (2016) -
Evidence Synthesis for Decision Making 4: Inconsistency in Networks of Evidence Based on Randomized Controlled Trials
por: Dias, Sofia, et al.
Publicado: (2013)